News from other sources...
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content
Safety, quality and clinical practice
WHO creates controversial 'reserve' list of antibiotics for superbug threats | The Washington Post
As part of its efforts to stop the spread of superbugs, the WHO released the largest change to its recommendations in relation to "last resort" antibiotics.
Pharmaceuticals
AstraZeneca sells migraine drug for up to $302 million | Reuters
AstraZeneca sold the drug to German company Grunenthal, adding to the number of drugs its sold or licensed recently.
Medical devices
Eko gets FDA clearance for digital stethoscope with ECG | Medcity News
Eko says the new stethoscope and heart monitor will be better for monitoring patients with heart conditions and that it could be used by patients for remote monitoring.
Clarify gets FDA clearance for connected home phototherapy device | Mobihealthnews
The FDA has cleared Clarify Medical's consumer phototherapy device for use in the treatment of skin conditions, including psoriasis and eczema.
Information technology
HHS issues warning for vigilance on WannaCry ransomware | Health Data Management
Two multi-state hospital systems are still dealing with the effects of last month's Wanna Cry ransomware attack, according to HHS.
In other news
Even moderate drinking may speed brain decline | Stat
Moderate drinking—between eight and 12 drinks per week—is linked to long-term changes in the brain, including shrinking of the hippocampus, a brain region that deals with memory and navigation, and degeneration of white matter in the brain.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 |